
NEW YORK, Oct. 17, 2022 /PRNewswire/ -- The transfection technologies market size is set to grow by USD 526.14 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 9.05% during the forecast period, according to Technavio.
The report offers an up-to-date analysis regarding the overall market environment, the current market scenario, and the latest trends and drivers. Read our FREE PDF Sample Report
- End-user
- Pharmaceutical And Biotechnology Companies
- Contract Research Organizations
- Academic And Research Institutes
- Geography
- North America
- Asia
- Europe
- Rest Of World (ROW)
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
North America will account for 42% of the market's growth during the forecast period. This growth is attributed to factors such as increasing investments in new manufacturing facilities equipped with bioprocessing units and other equipment required for processes such as cell line development and cell culture. Moreover, market growth in this region will be slower than the growth of the market in Asia. The US is a key country for the transfection technologies market in North America.
To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market. Some of the major vendors of the transfection technologies market include Altogen Biosystems, Bio Rad Laboratories Inc., Biontex Laboratories GmbH, Boca Scientific Inc., F. Hoffmann La Roche Ltd., GENLANTIS, Inovio Pharmaceuticals Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, POLYPLUS TRANSFECTION S.A, Promega Corp., PromoCell GmbH, QIAGEN NV, SignaGen Laboratories, Takara Holdings Inc, and Thermo Fisher Scientific Inc. The key offerings of some of these vendors are listed below:
- Bio Rad Laboratories Inc. - The company offers transfection technologies such as transfection lipid reagents.
- Lonza Group Ltd. - The company offers transfection technology such as a 4D nucleofector platform for a wide variety of cell types, even those traditionally hard to transfect.
- Merck KGaA - The company offers transfection technology such as X Tremegene Roche transfection reagents.
- Mirus Bio LLC - The company offers transfection technologies such as chemical transfection reagents that form transfection complexes with nucleic acid and facilitate delivery into the cell.
- OZ Biosciences - The company offers transfection technologies such as Magnetofaction and Lipofection.
- Transfection Technologies Market size
- Transfection Technologies Market trends
- Transfection Technologies Market industry analysis
Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Basic Plan" billed annually at USD 5000. View 100 reports and download 5 reports monthly!
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will assist transfection technologies market growth during the next five years
- Estimation of the transfection technologies market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the transfection technologies market
- Analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of transfection technologies market vendors
Microfluidics Technology Market by Material and Geography - Forecast and Analysis 2022-2026: The microfluidics technology market has been segmented by material (polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and others) and geography (North America, Europe, Asia, and ROW). By geography, 33% of the market's growth will originate from North America during the forecast period. By material, the polymer-based microfluidics segment will have significant market growth.
Crispr Technology Market by Application and Geography - Forecast and Analysis 2022-2026: The CRISPR technology market research report extensively covers market segmentation by application (biological application, agricultural application, industrial application, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). 44% of the market's growth will originate from North America during the forecast period. By application, the biological application segment will have significant growth.
Transfection Technologies Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.05% |
Market growth 2022-2026 |
USD 526.14 million |
Market structure |
Fragmented |
YoY growth (%) |
8.02 |
Regional analysis |
North America, Asia, Europe, and Rest of World (ROW) |
Performing market contribution |
North America at 42% |
Key consumer countries |
US, Canada, Germany, China, Japan, and India |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Altogen Biosystems, Bio Rad Laboratories Inc., Biontex Laboratories GmbH, Boca Scientific Inc., F. Hoffmann La Roche Ltd., GENLANTIS, Inovio Pharmaceuticals Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, POLYPLUS TRANSFECTION S.A, Promega Corp., PromoCell GmbH, QIAGEN NV, SignaGen Laboratories, Takara Holdings Inc, and Thermo Fisher Scientific Inc. |
Market Dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse Health Care Market Reports
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by End-user
- 5.1 Market segments
- Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
- Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
- 5.2 Comparison by End-user
- Exhibit 26: Chart on Comparison by End-user
- Exhibit 27: Data Table on Comparison by End-user
- 5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
- Exhibit 28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
- 5.4 Contract research organizations - Market size and forecast 2021-2026
- Exhibit 32: Chart on Contract research organizations - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Contract research organizations - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Contract research organizations - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Contract research organizations - Year-over-year growth 2021-2026 (%)
- 5.5 Academic and research institutes - Market size and forecast 2021-2026
- Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by End-user
- Exhibit 40: Market opportunity by End-user ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.5 Europe - Market size and forecast 2021-2026
- Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 China - Market size and forecast 2021-2026
- Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.9 Japan - Market size and forecast 2021-2026
- Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.10 Germany - Market size and forecast 2021-2026
- Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.11 Canada - Market size and forecast 2021-2026
- Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.12 India - Market size and forecast 2021-2026
- Exhibit 82: Chart on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 83: Data Table on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 84: Chart on India - Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on India - Year-over-year growth 2021-2026 (%)
- 7.13 Market opportunity by geography
- Exhibit 86: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 87: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 89: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 90: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 91: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 92: Matrix on vendor position and classification
- 10.3 Bio Rad Laboratories Inc.
- Exhibit 93: Bio Rad Laboratories Inc. - Overview
- Exhibit 94: Bio Rad Laboratories Inc. - Business segments
- Exhibit 95: Bio Rad Laboratories Inc. - Key news
- Exhibit 96: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 97: Bio Rad Laboratories Inc. - Segment focus
- 10.4 Lonza Group Ltd.
- Exhibit 98: Lonza Group Ltd. - Overview
- Exhibit 99: Lonza Group Ltd. - Business segments
- Exhibit 100: Lonza Group Ltd. - Key news
- Exhibit 101: Lonza Group Ltd. - Key offerings
- Exhibit 102: Lonza Group Ltd. - Segment focus
- 10.5 Merck KGaA
- Exhibit 103: Merck KGaA - Overview
- Exhibit 104: Merck KGaA - Business segments
- Exhibit 105: Merck KGaA - Key news
- Exhibit 106: Merck KGaA - Key offerings
- Exhibit 107: Merck KGaA - Segment focus
- 10.6 Mirus Bio LLC
- Exhibit 108: Mirus Bio LLC - Overview
- Exhibit 109: Mirus Bio LLC - Product / Service
- Exhibit 110: Mirus Bio LLC - Key news
- Exhibit 111: Mirus Bio LLC - Key offerings
- 10.7 OZ Biosciences
- Exhibit 112: OZ Biosciences - Overview
- Exhibit 113: OZ Biosciences - Product / Service
- Exhibit 114: OZ Biosciences - Key offerings
- 10.8 POLYPLUS TRANSFECTION S.A
- Exhibit 115: POLYPLUS TRANSFECTION S.A - Overview
- Exhibit 116: POLYPLUS TRANSFECTION S.A - Product / Service
- Exhibit 117: POLYPLUS TRANSFECTION S.A - Key news
- Exhibit 118: POLYPLUS TRANSFECTION S.A - Key offerings
- 10.9 Promega Corp.
- Exhibit 119: Promega Corp. - Overview
- Exhibit 120: Promega Corp. - Product / Service
- Exhibit 121: Promega Corp. - Key offerings
- 10.10 QIAGEN NV
- Exhibit 122: QIAGEN NV - Overview
- Exhibit 123: QIAGEN NV - Product / Service
- Exhibit 124: QIAGEN NV - Key news
- Exhibit 125: QIAGEN NV - Key offerings
- 10.11 SignaGen Laboratories
- Exhibit 126: SignaGen Laboratories - Overview
- Exhibit 127: SignaGen Laboratories - Product / Service
- Exhibit 128: SignaGen Laboratories - Key offerings
- 10.12 Thermo Fisher Scientific Inc.
- Exhibit 129: Thermo Fisher Scientific Inc. - Overview
- Exhibit 130: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 131: Thermo Fisher Scientific Inc. - Key news
- Exhibit 132: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 133: Thermo Fisher Scientific Inc. - Segment focus
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 134: Inclusions checklist
- Exhibit 135: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 136: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 137: Research methodology
- Exhibit 138: Validation techniques employed for market sizing
- Exhibit 139: Information sources
- 11.5 List of abbreviations
- Exhibit 140: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article